Latisse » fda

EyelashGrowthStore.com – Largest Online Retailer for Latisse Eyelash…

epionebh — Wed, 20 Apr 2011 12:23:29 +0000

Latisse

Latisse Faces Patent Challenge

epionebh — Tue, 13 Jul 2010 07:03:23 +0000

The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version. (Source: WSJ.com: Health)

More here:
Latisse Faces Patent Challenge

Latisse Faces Patent Challenge

epionebh — Tue, 13 Jul 2010 07:03:23 +0000

The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version.

Read the original post:
Latisse Faces Patent Challenge

Latisse Faces Patent Challenge

epionebh — Tue, 13 Jul 2010 07:03:23 +0000

The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version.

See the original post:
Latisse Faces Patent Challenge

FDA: Allergan’s Web Site Is Misleading

epionebh — Thu, 17 Sep 2009 00:56:01 +0000

The FDA said the Web site of Allergan’s Latisse is misleading because it suggests the company’s eyelash thickener is more safe than proven.

Go here to read the rest:
FDA: Allergan’s Web Site Is Misleading

Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse — First and Only Treatment Approved by the FDA for Hypotrichosis of…

epionebh — Mon, 29 Dec 2008 16:34:25 +0000

IRVINE, Calif.–(BUSINESS WIRE)–Dec 26, 2008 – Allergan, Inc.

Read the original:
Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse — First and Only Treatment Approved by the FDA for Hypotrichosis of…

FDA OKs 1st Eyelash Drug Latisse

epionebh — Mon, 29 Dec 2008 05:00:00 +0000

Title: FDA OKs 1st Eyelash Drug LatisseCategory: Health NewsCreated: 12/29/2008Last Editorial Review: 12/29/2008 (Source: MedicineNet Eyesight General) MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network , and receive $5 free advertising.

Continue reading here:
FDA OKs 1st Eyelash Drug Latisse

Allergan Eyelash Enhancer Approved

epionebh — Sat, 27 Dec 2008 15:50:04 +0000

Allergan received FDA approval to market Latisse, a beauty treatment that increases the length, thickness and darkness of eyelashes by using a drug the company developed to treat glaucoma.

See more here:
Allergan Eyelash Enhancer Approved

FDA Advisory Committee Unanimously Recommends Approval of Latisse (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes

epionebh — Mon, 08 Dec 2008 11:15:58 +0000

IRVINE, Calif.–(BUSINESS WIRE)–Dec 5, 2008 – Allergan, Inc. today announced the U.S. Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) voted unanimously (9-0) to recommend that the FDA approve Latisse..

See the original post here:
FDA Advisory Committee Unanimously Recommends Approval of Latisse (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes